The personalized nutrition market is undergoing rapid transformation, redefining how consumers approach health, diet, and wellness. Tailored recommendations are becoming mainstream as people look for health solutions specific to their unique needs and lifestyles. Market Outlook and Growth Potential According to a recent report, the personalized nutrition market size was valued at USD 11.3 billion in 2022 and is projected to nearly double to USD 23.3 billion by 2027. This rapid rise highlights how personalization is reshaping the future of nutrition and wellness. https://www.marketsandmarkets.com/Market-Reports/personalized-nutrition-market-249208030.html

The global pet food market size is projected to reach USD 47.4 billion by 2028 from USD 34.2 billion by 2023, at a CAGR of 6.8% during the forecast period in terms of value. The pet food market refers to the industry involved in producing various pet food products, including dry food, wet food, and supplements made from proteins, grains, vitamins, and minerals. This market is driven by the increasing demand for high-quality and nutritious pet food, as pet owners become more conscious about their pets’ health and well-being. https://www.marketsandmarkets.com/Market-Reports/global-pet-food-and-care-products-market-147.html

The global feed phosphate market is poised for robust growth, expanding from USD 2.79 billion in 2025 to USD 3.52 billion by 2030, achieving a CAGR of 6.0% throughout the forecast period. This growth is fueled by rising global demand for animal protein, advances in feed efficiency, increasing focus on animal health, supportive regulations, and advances in sustainable production practices. https://www.marketsandmarkets.com/Market-Reports/feed-phosphate-market-2507098.html

The postbiotics market size is projected to grow from USD 146.7 million in 2025 to USD 224.8 million by 2030, registering a CAGR of 8.9%. This reflects the growing demand for gut-friendly, immune-supporting solutions that seamlessly integrate into everyday wellness routines. Postbiotics—non-viable byproducts of microbial fermentation—are gaining momentum in functional foods, dietary supplements, and even personal care. Their shelf stability, formulation versatility, and safety profile make them a favorite among both manufacturers and modern consumers. https://www.marketsandmarkets.com/Market-Reports/postbiotics-market-237110254.html

The global modified cassava starch market is undergoing a transformation—driven by innovation, industrial modernization, and the rising demand for sustainable, plant-based solutions. Estimated at USD 2.52 billion in 2025 and modified cassava starch market size is projected to reach USD 3.37 billion by 2030, the market is expected to grow at a CAGR of 6.0%. This growth isn't just fueled by more cassava production, but also by how the starch is being reimagined across industries. https://www.marketsandmarkets.com/Market-Reports/modified-cassava-starch-market-104540605.html

The global vitamin D market is undergoing a strong growth phase, projected to rise from USD 1.3 billion in 2022 to USD 1.9 billion by 2027, growing at a healthy CAGR of 7.1%. This surge reflects a broader shift in consumer behavior—where wellness, prevention, and nutritional awareness are steering purchasing decisions across age groups and geographies. https://www.marketsandmarkets.com/Market-Reports/vitamin-d-market-22034298.html

The global beneficial insects market is buzzing with growth, and for good reason. Valued at US$ 773 million in 2022, the market is projected to more than double by 2028—reaching US$ 1,630 million, at a robust CAGR of 13.2%. This surge is driven by a pivotal shift in agriculture: the move away from chemical pesticides and toward eco-friendly, sustainable farming practices. https://www.marketsandmarkets.com/Market-Reports/beneficial-insects-market-186836772.html

The Global Consumer Packaged Goods market is entering a transformative era, driven by dynamic consumer preferences, technological innovation, and the growing importance of sustainability. The consumer-packaged goods market is estimated at USD 3,450.12 billion in 2025 and is projected to reach USD 4,235.01 billion by 2030, at a CAGR of 4.2% from 2025 to 2030. https://www.marketsandmarkets.com/Market-Reports/consumer-packaged-goods-market-125973933.html

As the global agricultural landscape evolves, one segment making significant strides is the global strobilurin market. Projected to grow from USD 5.53 billion in 2025 to USD 6.88 billion by 2030 at a CAGR of 4.47%, this market is gaining momentum due to the rising demand for high-yield, disease-resistant crops and the ongoing innovations in agrochemical technologies. Farmers and agribusinesses around the world are increasingly turning to strobilurin-based solutions as crop diseases become more widespread and the demand for greater agricultural productivity intensifies. These fungicides are known for their broad-spectrum activity, protective and curative properties, and compatibility with modern farming practices. Key players like Syngenta, BASF, and Corteva are fueling this growth through the development of advanced products and cutting-edge technologies. Additionally, government support, particularly in emerging economies, and the rising focus on sustainable and integrated pest management are creating a fertile environment for market expansion. https://www.marketsandmarkets.com/PressReleases/strobilurin-fungicide.asp

The Global Food Lyophilization Equipment Market is projected to grow from USD 1.19 billion in 2025 to USD 1.60 billion by 2030, recording a CAGR of 6.0% during the forecast period. This steady expansion is driven by the rising consumer preference for healthy, shelf-stable, and preservative-free food products. With a growing focus on clean-label foods that retain natural taste and nutritional value, food manufacturers are increasingly adopting freeze-drying (lyophilization) technologies. https://www.marketsandmarkets.com/Market-Reports/food-lyophilization-equipment-market-206957516.html

According to MarketsandMarkets, the global drip irrigation market is projected to expand from USD 5.6 billion in 2024 to USD 8.6 billion by 2029, reflecting a robust CAGR of 9.0%. Rising awareness of water scarcity and the necessity for sustainable agricultural practices are driving farmers worldwide to adopt drip irrigation systems, renowned for their efficiency and long-term economic advantages. https://www.marketsandmarkets.com/Market-Reports/drip-irrigation-systems-market-217216582.html

According to MarketsandMarkets, the global gluten-free food market is projected to grow from USD 7.70 billion in 2024 to USD 11.48 billion by 2029, at a compound annual growth rate (CAGR) of 8.3% during this period. Market Drivers: • Increased Diagnosis of Celiac Disease and Food Allergies: A rise in the diagnosis of celiac disease and other gluten-related disorders has led to greater demand for gluten-free foods. • Growing Health Awareness: Consumers are becoming more aware of the benefits of including nutritive and free-from foods in their daily diets, contributing to the market’s growth. • Prevalence of Irritable Bowel Syndrome (IBS): The increasing occurrence of IBS has driven consumers toward gluten-free food as a potential management strategy. • Availability in Retail Stores: The expanding presence of gluten-free foods in organized retail stores has made them more accessible to consumers. https://www.marketsandmarkets.com/Market-Reports/gluten-free-products-market-738.html

The specialty enzymes market is poised for growth, driven by technological advancements, expanding applications, and rising health consciousness. However, companies need to navigate regulatory challenges and production costs to capitalize on the market opportunities effectively. Specialty Enzymes Market Size and Growth • Current Market Size: The specialty enzymes market has been experiencing steady growth, driven by increasing demand across various industries such as pharmaceuticals, biotechnology, food and beverages, and diagnostics. • Projected Growth: According to MarketsandMarkets, the global specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%. To know more get PDF Copy: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21682828 Genetic Engineering and Sustainability: Enzymes Leading the Way Advancements in enzyme engineering have enabled the discovery of new enzymes from natural sources, ensuring their safety and efficacy in various applications. This includes their use in producing specialty pharmaceuticals and in biocatalytic processes. A recent study by the University of Notre Dame researchers in January 2022 emphasized biocatalytic depolymerization as an efficient and sustainable method for plastic treatment, addressing environmental concerns and enhancing recycling efforts. Additionally, the Manchester Institute of Biotechnology (MIB) has developed an enzyme engineering platform to improve plastic degradation using directed evolution techniques. These advancements in genetic engineering and enzyme engineering for sustainable practices highlight the specialty enzymes market’s growth potential, especially in addressing environmental issues and promoting eco-friendly solutions. What factors contribute to the high demand for animal-sourced enzymes in the specialty enzymes industry? Animal-derived enzymes are often favored for their high specificity and efficiency in catalyzing biochemical reactions, which are crucial for various specialized processes. Pancreatic enzymes like trypsin and chymotrypsin are widely used in drug formulation and the production of biologics. These enzymes facilitate the precise cleavage of peptide bonds, which is vital for the development and manufacturing of therapeutic proteins and peptides. Their specificity and activity levels make them indispensable in pharmaceutical applications, significantly contributing to their market share. In addition, animal-derived enzymes are essential in clinical diagnostics and the food industry. For example, rennet, obtained from calves’ stomachs, is used in the coagulation process of cheese production. In clinical settings, enzymes like lactase, sourced from animals, are used in diagnostic kits to test for lactose intolerance, demonstrating their versatility in both food processing and medical diagnostics. Moreover, thrombin, derived from bovine sources, plays a crucial role in surgical procedures by promoting blood clotting and is used in topical hemostatic agents to control bleeding during surgeries. The high efficacy and reliability of thrombin in medical applications underscore the importance of animal-derived enzymes in the specialty enzymes industry. North America Set to Lead the Specialty Enzymes Market North America holds the largest specialty enzymes market share in the specialty enzymes sector, driven by several key factors. The region boasts a strong pharmaceutical and biotechnology industry, supported by substantial investments in research and development. This investment climate encourages innovation, resulting in the creation of advanced enzyme-based solutions. Companies like Codexis, Inc. (US) lead the way in enzyme engineering, consistently developing new enzymes for pharmaceutical and industrial uses. Additionally, North America’s well-established healthcare infrastructure and high demand for diagnostic tools contribute to market growth. Specialty enzymes play a vital role in various diagnostic applications, such as ELISA (Enzyme-Linked Immunosorbent Assay) tests, which are extensively used in medical diagnostics. The rising prevalence of chronic diseases, including cancer and diabetes, in North America further fuels the demand for these advanced diagnostic tools, boosting the specialty enzymes market. Top Specialty Enzymes Companies • BRAIN Biotech AG (Germany) • Novozymes A/S (Denmark) • Codexis, Inc. (US) • Sanofi (France) • Merck KGaA (Germany) • Dyadic International Inc (US) • Advanced Enzyme Technologies (India) • Amano Enzyme Inc (Japan) • F. Hoffmann-La Roche Ltd (Switzerland) • New England Biolabs (US) Specialty Enzymes Market Growth Drivers • Pharmaceutical Industry Demand: Specialty enzymes are extensively used in pharmaceutical applications for drug formulation and biocatalysis, boosting market demand. • Advancements in Biotechnology: Innovations in enzyme engineering and biotechnology are enhancing enzyme efficiency and expanding their application range. • Food and Beverage Industry: Enzymes play a crucial role in improving food quality, processing, and shelf life, increasing their demand in this sector. • Rising Health Awareness: Growing consumer preference for natural and organic products is driving the demand for enzymes in nutraceuticals and dietary supplements.

The biocontrol market refers to the use of natural organisms, substances, or methods to manage agricultural pests and diseases, reducing the reliance on chemical pesticides. This approach integrates biological agents such as predators, parasitoids, pathogens, and beneficial microorganisms to control harmful insects, weeds, and plant diseases. The global biocontrol market size was projected to reach USD 6.6 billion in 2022 and is expected to nearly double to USD 13.7 billion by 2027, growing at a CAGR of 15.8% during this period. Biocontrol solutions, including biopesticides and semiochemicals, are derived from natural sources such as microbials, biochemicals, and macrobials. Unlike traditional agricultural chemicals, which pose risks to both the environment and human health, biocontrol products offer a safer alternative. Policymakers, particularly in North America and Europe, are increasingly regulating chemical pesticides to ensure food safety, environmental protection, and sustainability. Rising consumer awareness and the growing demand for organic food are also key drivers, fueling the expansion of the biocontrol market. https://www.marketsandmarkets.com/PressReleases/biocontrol.asp

The nutraceutical ingredients market encompasses bioactive compounds that provide health benefits beyond basic nutrition. These ingredients are used in functional foods, beverages, dietary supplements, and personal care products. The global nutraceutical ingredients market size valued at USD 105.2 billion in 2024, showcases a remarkable growth projection, anticipated to escalate to USD 136.1 billion by 2029, indicating a robust compound annual growth rate (CAGR) of 5.3% during the forecast period. https://www.marketsandmarkets.com/Market-Reports/nutraceutical-ingredient-market-1319.html

The global microencapsulation market is on an impressive trajectory, with projections estimating its value to grow from USD 15.38 billion in 2024 to USD 24.07 billion by 2029, at a compound annual growth rate (CAGR) of 9.4%. This growth is driven by a surge in the application of microencapsulation across various industries, notably pharmaceuticals, food, and personal care products. https://www.marketsandmarkets.com/Market-Reports/microencapsulation-market-83597438.html